CannTrust

About CannTrust

CannTrust, a company that has faced regulatory challenges, is re-entering the Canadian medical cannabis market with the launch of its new brand, estora™. This strategic move is accompanied by the rollout of an e-commerce platform, estoramedical.com, which will serve as the primary channel for product sales. The estora™ brand is designed with patients in mind, offering a portfolio of medical cannabis products in various formats, including oil drops, capsules, and dried flowers. The company emphasizes standardized processes to ensure product consistency for its customers.

To facilitate the distribution of its products, CannTrust has partnered with Pineapple Express Delivery for same-day and next-day delivery services. This partnership aims to provide a seamless and efficient experience for patients accessing estora™ products. The company is currently operating under CCAA (Companies' Creditors Arrangement Act) protection, which provides a framework for its restructuring and re-launch efforts. The re-entry into the medical market and the introduction of the estora™ brand are significant steps in CannTrust's plan to rebuild its operations and regain the trust of patients and stakeholders.